Carrier-based intralymphatic cisplatin chemotherapy for the treatment of metastatic squamous cell carcinoma of the head & neck

Therapeutic Delivery

Volumn 1, Issue 2, 2010, Pages 237-245

  Cai, Shuang ^a   Xie, Yumei ^b   Davies, Neal M ^c   Cohen, Mark S ^d   Forrest, M Laird ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HYALURONIC ACID; NANOCARRIER;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER LOCALIZATION; CANCER SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG RETENTION; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; HEAD AND NECK CARCINOMA; HEARING IMPAIRMENT; HUMAN; HUMAN CELL; KIDNEY NECROSIS; LOW DRUG DOSE; MALE; METASTASIS; MOUSE; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SLOW DRUG RELEASE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TOXICITY TESTING; TREATMENT DURATION; TUMOR XENOGRAFT;

EID: 79954990663     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.10.38     Document Type: Article

References (25)

1. Kurtin SE. Systemic therapies for squamous cell carcinoma of the head and neck. Semin. Oncol. Nurs. 25(3), 183-192 (2009).
2. Gil Z, Fliss DM. Contemporary management of head and neck cancers. Isr. Med. Assoc. J. 11(5), 296-300 (2009).
3. Forastiere AA. Chemotherapy in the treatment of locally advanced head and neck cancer. J. Surg. Oncol. 97(8), 701-707 (2008). (Pubitemid 351812972)
4. Chandana SR, Conley BA. Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects. Curr. Opin. Oncol. 21(3), 218-223 (2009).
5. Jeong YI, Kim ST, Jin SG et al. Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation. J. Pharm. Sci. 97(3), 1268-1276 (2008).
6. Cai S, Xie Y, Bagby T, Cohen MS, Forrest ML. Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. J. Surg. Res. 147(2), 247-252 (2008).
7. Pereira-Maia E, Garnier-Suillerot A. Impaired hydrolysis of cisplatin derivatives to aquated species prevents energy-dependent uptake in glc4 cells resistant to cisplatin. J. Biol. Inorg. Chem. 8(6), 626-634 (2003). (Pubitemid 36960810)
8. Zuur CL, Simis YJ, Verkaik RS et al. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer. Radiother. Oncol. 89(1), 38-43 (2008).
9. Ekborn A, Lindberg A, Laurell G, Wallin I, Eksborg S, Ehrsson H. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig. Cancer Chemother. Pharmacol. 51(1), 36-42 (2003). (Pubitemid 36057021)
10. Vreeburg GC, Stell PM, Holding JD, Lindup WE. Cisplatin-albumin complex for treatment of cancer of the head and neck. J. Laryngol. Otol. 106(9), 832-833 (1992).
11. Clerici WJ, Hensley K, Dimartino DL, Butterfield DA. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear. Res. 98(1-2), 116-124 (1996). (Pubitemid 26306760)
12. Huang X, Whitworth CA, Rybak LP. Ginkgo biloba extract (egb 761) protects against cisplatin-induced ototoxicity in rats. Otol. Neurotol. 28(6), 828-833 (2007). (Pubitemid 47329900)
13. Campbell KC, Meech RP, Klemens JJ et al. Prevention of noise-and drug-induced hearing loss with d-methionine. Hear. Res. 226(1-2), 92-103 (2007). (Pubitemid 46428036)
14. Kalcioglu MT, Kizilay A, Gulec M et al. The protective effect of erdosteine against ototoxicity induced by cisplatin in rats. Eur. Arch. Otorhinolaryngol. 262(10), 856-863 (2005). (Pubitemid 41605803)
15. Chen FA, Kuriakose MA, Zhou MX, Delacure MD, Dunn RL. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model. Head Neck 25(7), 554-560 (2003). (Pubitemid 36736875)
16. Cai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents. J. Pharm. Sci. 99(6), 2664-2671 (2010).
17. Kobayashi H, Ogawa M, Kosaka N, Choyke PL, Urano Y. Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents. Nanomedicine 4(4), 411-419 (2009).
18. Vieira SC, Sousa RB, Tavares MB et al. Preoperative pelvic lymphoscintigraphy is of limited usefulness for sentinel lymph node detection in cervical cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 145(1), 96-99 (2009).
19. McElroy M, Bouvet M, Hoffman RM. Chapter 2. Color-coded fluorescent mouse models of cancer cell interactions with blood vessels and lymphatics. Methods Enzymol. 445, 27-52 (2008).
20. Dunne AA, Boerner HG, Kukula H et al. Block copolymer carrier systems for translymphatic chemotherapy of lymph node metastases. Anticancer Res. 27(6B), 3935-3940 (2007).
21. Xie M, Zhou L, Hu T, Yao M. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts. Anticancer Drugs 18(4), 459-466 (2007). (Pubitemid 46712409)
22. Stakisaitis D, Dudeniene G, Jankunas RJ, Grazeliene G, Didziapetriene J, Pundziene B. Cisplatin increases urinary sodium excretion in rats: gender-related differences. Medicina (Kaunas) 46(1), 45-50 (2010).
23. Van Bokhorst-De Van Der Schueren MAE, Van Leeuwen PA, Kuik DJ et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 86(3), 519-527 (1999). (Pubitemid 29347416)
24. Dahlstrom KR, Little JA, Zafereo ME, Lung M, Wei Q, Sturgis EM. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck 30(1), 75-84 (2008). (Pubitemid 351158324)
25. Onyango JF, Awange DO, Njiru A, Macharia IM. Pattern of occurrence of head and neck cancer presenting at Kenyatta National Hospital, Nairobi. East Afr. Med. J. 83(5), 288-291 (2006). (Pubitemid 44022613)